|
 |
granisetronThis page contains recent news articles, when available, and an overview of granisetron but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.And AP Pharma Inc., of Redwood City, Calif., has a March 18 PDUFA date for APF530, a long-acting formulation of granisetron, in chemotherapy-induced nausea ... BioWorld Online Almac Discovery Announce Commencement of Phase I Trials of Granisetron Nasal Spray - Dec 17, 2009 Almac Discovery today announced the start of Phase I clinical trial of the novel intranasal Granisetron product. This product, which uses Archimedes' ... PR-CANADA.net (press release) Completion of Phase I Clinical Trial of Sancuso in Japanese Volunteers - Oct 30, 2009 Sancuso is the first and only commercialized extended release granisetron transdermal product. Sancuso was approved for the prevention of ... Reuters China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and ... - Nov 11, 2009 Our Other Products category (including our tumor drug Granisetron and various other products) saw an increase of 36% over last year to $2.3 million. ... CNNMoney.com (press release) China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and ... - Nov 13, 2009 Our Other Products category (including our tumor drug Granisetron and various other products) saw an increase of 36% over last year to $2.3 million. ... PR-AU.com... (press release) A.P. Pharma Announces Private Equity Placement - Oct 20, 2009 APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron utilizing ... Reuters India's Cipla gets FDA nod for granisetron HCL - Mar 3, 2008 MUMBAI, March 3 (Reuters) - Indian drugmaker Cipla Ltd (CIPL.BO) has received approval from the US Food and Drug Administration for granisetron ... Reuters Anti-Nausea Patch Approved for Chemo Patients - Sep 17, 2008 The Sancuso (granisetron transdermal system) patch releases the active drug slowly into the bloodstream, providing up to five days relief from symptoms that ... Forbes Anti-nausea patch for chemo patients approved - Sep 16, 2008 The patch, called Sancuso, is worn on the arm and delivers a widely used anti-nausea medicine, known as granisetron, through the skin. ... msnbc.com Orchid pharma's anti-nausea tablets get US approval - Feb 14, 2008 ...that US Food and Drug Administration (USFDA) has approved sale of its non-antibiotic, anti-emetic granisetron hydrochloride tablets in that country. ... सिफी - सिफी Granisetron (Systemic). - Feb 1, 2006 Granisetron ( gra-NI-se-tron) is used to prevent the nausea and vomiting that may occur after treatment with anticancer medicines (chemotherapy) or with ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com The Effect of Granisetron on in Vitro Metabolism of Doxorubicin,... - May 10, 2005 Objective: Doxorubicin, irinotecan and etoposide are all associated with the debilitating side-effects of nausea and vomiting, thereby necessitating ... RedOrbit Granisetron and Ondansetron for Prevention of Nausea and Vomiting in ... - Jan 8, 2005 Modified radical mastectomy is associated with a relatively high incidence of postoperative nausea and vomiting (PONV). This study was undertaken to ... RedOrbit Teva gets FDA OK for generic Kytril - Jan 3, 2008 The FDA approved Teva's abbreviated new drug application to market granisetron hydrochloride (Kytril) injection, 1 milligram single-dose vials and 1 mg ... Boston Globe China Pharma Holdings Inc - CPHI: Receives Approval for Granisetron … - Oct 9, 2006 Granisetron hydrochloride is indicated for the prevention of nausea and vomiting associated with radiation treatment and chemotherapy in cancer patients. ... Pay-Per-View - Knobias - Factiva, from Dow Jones … Receives Tentative Approval for Granisetron Hydrochloride Injection,... - Sep 11, 2007 SCHAUMBURG, Ill. -- Abraxis Pharmaceutical Products (APP), the hospital-based business of Abraxis BioScience, Inc. (NASDAQ:ABBI), today announced that it ... Free with registration - Business Wire - AccessMyLibrary.com AP Pharma drug fails to meet superiority goal - Sep 30, 2008 The trial was comparing the efficacy of 5mg and 10mg doses of APF530, or granisetron, with Aloxi, which is already indicated for the treatment of CINV, ... Reuters AP Pharma Reports All Clinical Endpoints Achieved in APF530 Phase 2 … - Oct 4, 2005 APF530, which contains the anti-nausea drug granisetron formulated with the ... The pharmacokinetic evaluation of granisetron in all three dose groups has ... RedOrbit GRANISETRON (Oral route, Intravenous route) - gra-NI-se-tron.(Drug … - May 1, 2007 Granisetron is used to prevent the nausea and vomiting that may occur after treatment with anticancer medicines (chemotherapy) or with radiation therapy. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com China' SFDA clears China Pharma's granisetron.(Chinese State Food and... - Oct 16, 2006 China Pharma Holdings say it has received approval from the Chinese State Food and Drug Administration (SFDA) to manufacture and market its granisetron HCl ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Teva Announces Tentative Approval of Granisetron Hydrochloride … - Aug 17, 2005 JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the US Food and Drug Administration has granted tentative approval for ... $4.95 - Business Wire - ECNext Barr Labs: FDA OKs its generic Kytril - Jan 2, 2008 The US Food and Drug Administration approved Barr's abbreviated new drug application for granisetron hydrochloride, known as Kytril, at 1 milligram. ... Boston Globe Abraxis receives tentative FDA approval for Granisetron - Nov 7, 2007 NEW YORK, September 11 (newratings.com) - Abraxis BioScience Inc (ABBI) Tuesday announced that it has received tentative approval for its treatment called ... newratings.com Translational Research Develops Intranasal Formulation of Granisetron,... - May 26, 2006 Granisetron is commonly used in reducing side effects of antitumor therapy. In experiments on monkeys, the company confirmed that the new formulation has an ... japancorp.net Granisetron Hydrochloride Tentatively Approved - Jan 22, 2007 The FDA has tentatively approved Barr Laboratories' generic version of Roche Laboratories' Kytril (granisetron hydrochloride) 1 mg tablets, indicated for ... Facts and Comparisons AP Pharma Initiates APF530 Phase 2 Clinical Trial Program in Cancer … - Apr 28, 2005 Granisetron is one of a class of 5-HT3 antagonists which have revolutionized ... Granisetron is currently administered by intravenous (IV) injection and is ... RedOrbit The Hindu Business Line - Mar 24, 2008 ...medicine for blood cancer;b) Anastrazole medicine for breast cancer;c) Granisetron treatment for nausead) Rizatriptan for the treatment of migrane. ... Hindu Business Line Scottish firm targets South Korea for cancer patch - Aug 13, 2007 Granisetron is a well-known 5-HT3 receptor agonist, and a widely-used treatment for ... Granisetron is the active ingredient in Roche's drug Kytril, ... In-PharmaTechnologist.com AP Pharma Completes Financing for up to $30 Million; Sells Royalty … - Jan 18, 2006 APF530, which contains the anti-nausea drug granisetron formulated with the ... The pharmacokinetic evaluation of granisetron in all three dose groups ... biotech-intelligence.com AP Pharma Reports All Clinical Endpoints Achieved in APF530 Phase 2 … - Sep 29, 2005 APF530, which contains the anti-nausea drug granisetron formulated with the ... The pharmacokinetic evaluation of granisetron in all three dose groups has ... $4.95 - Business Wire - ECNext APP Pharmaceuticals Launches Granisetron Hydrochloride Injection, … - Jan 17, 2008 SCHAUMBURG, Ill. -- APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, ... Free with registration - Business Wire - AccessMyLibrary.com … .(receives tentative approval to its granisetron HCl injection... - Sep 26, 2005 The FDA last month granted tentative approval to Teva's granisetron HCl injection formulations, the generic equivalents to Hoffman-La Roche's anti-nauseant ... Free with registration - Drug Store News - AccessMyLibrary.com … for Additional Dosages of Granisetron Hydrochloride Injection, USP - Jul 3, 2008 According to IMS data, branded sales of these two dosage forms of Granisetron were approximately $72.2 million in 2007. The company currently markets ... Genetic Engineering News - Genetic Engineering News (press release) Drugs for Postoperative Nausea May Not Help Most Patients - Jul 19, 2006 The drugs found to reliably prevent nausea and vomiting after surgery, according to the review, are cyclizine, droperidol, granisetron, metoclopramide, ... Today's SurgiCenter … For Additional Dosages Of Granisetron Hydrochloride Injection, USP - Jul 7, 2008 According to IMS data, branded sales of these two dosage forms of Granisetron were approximately $72.2 million in 2007. The company currently markets ... Medical News Today - Medical News Today (press release) Teva gets tentative appro for generic granisetron. - Aug 29, 2005 Israel's Teva Pharmaceutical Industries has been granted tentative approval for granisetron HCl injection, 1mg/mL single dose vials and 4mg/4mL multi-dose ... $4.95 - Pharma Marketletter - ECNext The role of 5-H[T.sub.3] receptor antagonists in preventing: postopera... - Jan 1, 2006 Three other 5-[HT.sub.3] antagonists have since been approved for CINV: granisetron, dolasetron, and palonosetron; however, the only 5-[HT.sub.3] ... $4.95 - AORN Journal - ECNext … Final FDA Approval for Granisetron Hydrochloride Tablets. - PR … - Feb 1, 2008 Mylan Announces Final FDA Approval for Granisetron Hydrochloride Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Granisetron Plus Aprepitant Can Prevent Nausea and Vomiting During … - Feb 8, 2008 By Shazia Qureshi. PARIS, FRANCE -- February 8, 2008 -- The combination antiemetic regimen of granisetron plus aprepitant seems to be effective in ... DG News ProStrakan and JapanBridge Partner to Develop Sancuso(R) in Japan, … - May 23, 2008 Granisetron is an established 5-HT3 receptor antagonist that prevents this side ... Sancuso is designed to steadily deliver granisetron into the bloodstream ... RedOrbit Orchid Gets USFDA Nod For Granisetron Hydrochloride Tabs - Feb 15, 2008 Orchid Chemicals is the first Indian pharmaceutical company to receive approval for the non-antibiotic product that is available in 1 mg dosage strength, ... Stock watch - Stock Watch … , Inc. Announces the Launch of Granisetron Hydrochloride Tablets,... - Jan 2, 2008 Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research ì‚°ì¿ ì†Œ(SANCUSO) êµë‚´ 공급…年 매출 150ì–µì›? 기대 - Aug 13, 2007 ...세계 최초ì?˜ 패치형 í•êµ¬í† ì œí’ˆìœ¼ë¡œ, êµ¬í† ì–µì œìš©ìœ¼ë¡œ ë„?리 ì“°ì?´ê³ 있는 ê·¸ë?¼ë‹ˆì„¸íŠ¸ ë¡ (granisetron)ì?´ 주성분ì?´ë‹¤. LGìƒ?명과학 관계ìž?는 "2009ë…„ 하반기경 Â´ì‚°ì¿ ì†ŒÂ´ë¥¼ ... EBN뉴스센터 AP Pharma Reports Second Quarter Financial Results; Patient Enrollment... - Aug 8, 2005 Sustained plasma levels of granisetron were observed over five days. ... APF530, which contains the anti-nausea drug granisetron, formulated with the ... $4.95 - Business Wire - ECNext Natco Pharma gets USFDA nod for API facility in Andhra Pradesh - Mar 20, 2008 The approved products include Imatinib Mesylate (medicine for blood cancer), Anastrazole (breast cancer), Granisetron (nausea) and Rizatripan (migraine). ... Stock watch - Stock Watch Analgesic effect of acetaminophen in humans: First evidence of a... - Jun 27, 2005 The area under the curve (0-4 hours) (mean SD) of acetaminophen/tropisetron and the area under the curve of acetaminophen/granisetron were compared with the ... Nature.com Chemotherapy; Potential signal for arrhythmias and cardiac arrest are... - Jan 10, 2006 The PRR, used as a parameter to detect a potential signal within the database, was 3.23, 1.31, and 1.13 for dolasetron, ondansetron, and granisetron, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones FDA дало предварительное одобрение препарата Granisetron … - Sep 19, 2007 Inc., получила предварительное одобрение регулÑ?тивных органов СШÐ? на инъекционный препарат Granisetron Hydrochloride 1мг во флаконах по 1мл, ... ФармацевтичеÑ?кий веÑ?тник ProStrakan's Sancuso launched in USA. - Nov 10, 2008 Scottish drugmaker ProStrakan says that Sancuso (granisetron transdermal patch) has been launched in the USA for patients with chemotherapy-induced nausea ... $9.94 - Pharma Marketletter - Alacra Store Preventing Chemotherapy-Induced Emesis - Sep 14, 2008 Granisetron has already been approved in Japan, and patients were randomized to receive either agent. Dexamethasone was also administered to all patients: ... Medscape Subcutaneous administration of an antiemetic for treating vomiting … - Nov 19, 2007 The subcutaneous administration of granisetron, an antiemetic pharmaceutical drug ... All were medicated with granisetron, using one of the two forms of ... News-Medical.net FDA tentative generics approvals--2005.(Special Report)(Illustration) - Feb 27, 2006 30 Teva Pharmaceuticals USA mg and 35 mg Granisetron HCl injection, 1 mg/ml; 4 Sicor Pharmaceuticals Inc. ml vials Granisetron HCl injection, 1 mg/ml; ... Free with registration - Chain Drug Review - AccessMyLibrary.com JAPAN'S SHIN NIPPON READIES TRIALS ON IN-HOUSE NASAL ANTI- … - Nov 27, 2007 Granisetron is already available in an injection preparation and an oral ... The granisetron is coated on micrograins that measure just 100 microns in ... $4.95 - AsiaPulse News - ECNext å??大医å¦çª?ç ´ï¼šæ™•èˆ¹ç²˜è´´å‰‚æ²»ç–—åŒ–ç–—å‘•å?? - Dec 10, 2008 ...阻æ–剂Sancusoè¿žç»é‡Šæ”¾è?¯ç‰©granisetron，阻æ¢è¡€æ¸…ç´ å?—体，缓解æ?¶å¿ƒå??胃的感觉。 肿瘤患者å?¯ä»¥é€šè¿‡æœ?用这ç§?è?¯ç‰©çš„å?¯æº¶æ€§ç±»åž‹ã€?è?¯ç‰‡å’Œæ³¨å°„è¿™ç§?处方è?¯ï¼Œæ²»ç–—å‘•å??现象。 ... 新浪网 FDA tentative generics approvals--2005.(Special Report)(Illustration)... - Feb 27, 2006 Zolpidem tartrate tablets, 5 mg and 10Caraco Pharmaceutical mgLaboratories Ltd. Granisetron HCl injection, 1 mg Baxter Healthcare Corp. ... Pay-Per-View - Chain Drug Review - HighBeam Research 'Highly Emetogenic, Delayed Onset' Key - Nov 19, 2007 Over the summer, AP Pharma Inc. raised $35 million for its Phase III CINV compound APF530 (granisetron), a 5HT3 antagonist that deploys AP's polymer-based ... BioWorld Online - BioWorld Online Nausea and vomiting with high-dose chemotherapy and stem cell rescue ... - Aug 25, 2008 Comparisons of ondansetron and granisetron have been reported by several groups, ... In a smaller study (n=34), oral ondansetron and oral granisetron were ... Nature.com Association of the ABCB1 3435C>T polymorphism with antiemetic … - Apr 1, 2005 ...to tropisetron, ondansetron, or granisetron. The efficacy of antiemetic treatment was documented by self-report charts for 5 days after chemotherapy. ... Nature.com Acetaminophen/Paracetamol Painkiller Blocked by Anti-Nausea Drugs - May 22, 2006 Rather, the results favor a pharmacodynamic interaction between acetaminophen and tropisetron and granisetron - one that needs to be studied further, ... Cancerpage.com Q4 2006 MGI PHARMA Earnings Conference Call - Part 2. - Feb 7, 2007 GEOFF MEACHAM: Generic granisetron, when it-- BILL SPENGLER: Generic granisetron, sure, the arbitrage there as you know, generic granisetron can already be ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Pharmacokinetics of Palonosetron in Combination With Aprepitant in … - Jun 7, 2005 In addition, palonosetron has a binding affinity (pK^sub i^) for the 5-HT3 receptor at least 30-fold higher than that of ondansetron, granisetron, ... RedOrbit Unbinding Pathways of an Agonist and an Antagonist From the 5- HT^ … - Mar 30, 2006 The exit routes for an agonist (5-HT) and an antagonist (granisetron) were similar, with trajectories toward the membrane and outward from the ligand ... RedOrbit Press Release: Ranbaxy Gains Final Approval for Sertraline … - Feb 8, 2007 Application (ANDA) for Granisetron Hydrochloride Tablets, 1mg by the U.S. Food ... Laboratories' Granisetron Hydrochloride Tablets are AB rated to KYTRIL(R) ... Pay-Per-View - PR Newswire - HighBeam Research APP PHARMACEUTICALS GETS APPROVALS FOR ADDITIONAL … - Aug 1, 2008 According to IMS data, branded sales of these two dosage forms of Granisetron were approximately $72.2 million in 2007. The company currently markets ... Entrepreneur Orchid receives two US FDA approvals - Mar 15, 2008 Granisetron is a new generation non-antibiotic product. ... Granisetron can be used to treat nausea and vomiting caused be radiotherapy, chemotherapy and ... Express Pharma FDA, 암환ìž?ìš© í•êµ¬í† 패치 'ì‚°ì¿ ì†Œ' 승ì?¸ - Sep 16, 2008 ...ì‚°ì¿ ì†Œì?˜ 성분ì?€ ê·¸ë?¼ë‹ˆì„¸íŠ¸ë¡ (granisetron). 팔ì—? 부착하는 패치형태. 한번 부착으로 5ì?¼ ì •ë?„ 약효가 ìœ ì§€ë?œë‹¤. ì‚°ì¿ ì†ŒëŠ” 올해 ë§?쯤ì—? 출시ë? 것으로 예ìƒ?ë?œë‹¤. ... ë?°ì?¼ë¦¬íŒœ Press Release: Ranbaxy Receives Tentative Approval to Market … - Jun 22, 2005 Application (ANDA) for Granisetron Hydrochloride Tablets, 1mg by the U.S. Food ... Laboratories' Granisetron Hydrochloride Tablets are AB rated to KYTRIL(R) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Mylan Announces Final FDA Approval for Sotalol … - Feb 8, 2007 Application (ANDA) for Granisetron Hydrochloride Tablets, 1mg by the U.S. Food ... Laboratories' Granisetron Hydrochloride Tablets are AB rated to KYTRIL(R) ... Pay-Per-View - PR Newswire - HighBeam Research CHINA PHARMA RECEIVES SFDA APPROVAL FOR NAUSEA DRUG - Oct 10, 2006 Granisetron hydrochloride is indicated for the prevention of nausea and vomiting associated with radiation treatment and chemotherapy in cancer patients. ... Pay-Per-View - Daily International Pharma Alert - Factiva, from Dow Jones AP Pharma Revises Target Date for APF530 NDA - Dec 18, 2008 APF530 is delivered by a single subcutaneous injection and contains the 5HT 3 antagonist granisetron. Injections and oral tablets containing granisetron are ... Genetic Engineering News - Genetic Engineering News (press release) Article: Requip now has generic competitors.(RX/Generic Drugs) -... - Jun 30, 2008 Application (ANDA) for Granisetron Hydrochloride Tablets, 1mg by the U.S. Food ... Laboratories' Granisetron Hydrochloride Tablets are AB rated to KYTRIL(R) ... Pay-Per-View - Chain Drug Review - HighBeam Research Press Release: Mylan Announces Final FDA Approval for Ropinirole … - May 7, 2008 Application (ANDA) for Granisetron Hydrochloride Tablets, 1mg by the U.S. Food ... Laboratories' Granisetron Hydrochloride Tablets are AB rated to KYTRIL(R) ... Pay-Per-View - PR Newswire - HighBeam Research Article: Roxane rollout.(Generic Drugs)(Roxane Laboratories Inc. … - May 19, 2008 Application (ANDA) for Granisetron Hydrochloride Tablets, 1mg by the U.S. Food ... Laboratories' Granisetron Hydrochloride Tablets are AB rated to KYTRIL(R) ... Pay-Per-View - Chain Drug Review - HighBeam Research AP Pharma Reports 2005 First Quarter Results; Cancer Patients... - May 10, 2005 APF530 contains the anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug delivery system. ... $4.95 - Business Wire - ECNext Press Release: Palonosetron: The Long-Lasting Antiemetic Action Finds... - Sep 12, 2008 Palonosetron exhibits allosteric binding and positive cooperativity, unlike granisetron and ondansetron which exhibit simple bimolecular binding and no ... Pay-Per-View - PR Newswire Europe - HighBeam Research Competitors by Product Report - Jan 26, 2008 Granisetron Hydrochloride Injection; Ondansetron Injection. Barr Pharmaceuticals, Inc. (BRL) Products:. Granisetron Hydrochloride; Ondansetron Hydrochloride ... $75.00 - Revere Reports - Revere AP Pharma Reports Third Quarter Financial Results - Nov 13, 2007 We selected granisetron because it is a potent drug that blocks a ... Additionally, the applicable granisetron US patent expires on December 29, 2007. ... Genetic Engineering News - Genetic Engineering News (press release) AP Pharma Reports Results for the First Quarter 2007 - Mar 31, 2007 We selected granisetron because it is a potent drug which blocks a specific ... Additionally, the applicable granisetron patent will expire in the United ... businesswire.com AP Pharma Reports Results for the First Quarter 2008 - May 15, 2008 We selected granisetron because it is a potent drug that blocks a ... Additionally, the applicable granisetron US patent expired on December 29, 2007. ... Genetic Engineering News - Genetic Engineering News (press release) AP Pharma Reports Results for the Second Quarter 2008 - Aug 14, 2008 We selected granisetron because it is a potent drug that blocks a ... Additionally, the applicable granisetron US patent expired on December 29, 2007. ... RedOrbit Cancer Therapy; New data illuminates research in cancer therapy - Apr 4, 2006 ...regimens composed of highly or moderately emetogenic agents were examined for their antiemetic responses to tropisetron, ondansetron, or granisetron." ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones AP Pharma Reports 2004 Fourth Quarter and Full Year Results; IND … - Mar 10, 2005 In the fourth quarter of 2004, we evaluated 2.5 mg, 5 mg, and 10 mg doses of the anti-nausea drug granisetron, the active pharmacological agent in APF530, ... $4.95 - Business Wire - ECNext AP Pharma Reports Results for the First Quarter 2007.(Financial... - May 8, 2007 We selected granisetron because it is a potent drug which blocks a specific ... Additionally, the applicable granisetron patent will expire in the United ... $4.95 - Business Wire - ECNext Myogen Reports Positive Results for Darusentan Phase 2b Trial in … - Aug 18, 2005 ...approval for the Company's ANDAs for Granisetron HCl Injection, 1 mg/mL single dose vials and Granisetron HCl Injection, 4 mg/4mL in multi-dose vials. ... $4.95 - M2 Presswire - ECNext Press Release: Myogen Reports Positive Results for Darusentan Phase … - Aug 18, 2005 Myogen Reports Positive Results for Darusentan Phase 2b Trial in Resistant Hypertension and Teva Announces Tentative Approval of Granisetron Hydrochloride ... Pay-Per-View - M2 Presswire - HighBeam Research Minnesota - Official Notices - Department of Human Services - Jan 3, 2006 J1626 Granisetron [for more than 4 consecutive weeks of continuous treatment] J2405 Ondansetron [for more than 4 consecutive weeks of continuous treatment] ... Pay-Per-View - RegAlert - Factiva, from Dow Jones Barr Receives Tentative Approval For Generic KYTRIL(R) Tablets, 1mg (... - Jan 20, 2007 KYTRIL (granisetron hydrochloride) Tablets, 1mg (base) is indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of ... Medical News Today - Medical News Today (press release) Prostrakan and Paladin Complete Agreement for Abstral ® and Sancuso … - Dec 22, 2008 Sancuso ® is a transdermal patch that delivers granisetron, an established 5HT3 receptor antagonist, and is indicated for the prevention of nausea and ... marketwire.com AP Pharma Reports 2005 Full Year and Fourth Quarter Results; APF530 … - Mar 15, 2006 APF530, which contains the anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) bioerodible drug delivery system, ... Free with registration - Business Wire - AccessMyLibrary.com FDA clears APP's Polmyxin B Sulfate. - Jan 21, 2008 The Schaumburg, Illinois-headquartered firm also announced that it has launched its granisetron HCl product for the prevention of the nausea and vomiting ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Oral agent shows efficacy as second-line PCa therapy.(Prostate Cancer) - Feb 1, 2007 ...plus growth factor support with granisetron (Kytril), 1 mg twice daily on days 1 to 5 ... or with prednisone and placebo satraplatin and granisetron. ... Free with registration - Urology Times - AccessMyLibrary.com Hawthorn Pharmaceuticals, Inc. Receives FDA Approval On Granisolâ„¢ … - Mar 17, 2008 Granisolâ„¢ (granisetron HCl) is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, ... Medical News Today - Medical News Today (press release) Actavis launches three new generic products in Europe - May 29, 2006 Granisetron reduces nausea and vomiting, common adverse effects associated with chemotherapy. Each of these products will be marketed by Actavis' European ... webwire.com Growth Watch. - Aug 14, 2007 Granisetron hydrochloride which was launched in the middle of the second quarter is experiencing encouraging sales. Gross profit increased 108.4% to $3.90 ... Free with registration - M2 Presswire - AccessMyLibrary.com AP Pharma Seeks Approval for Trial Protocol - Jan 25, 2006 APF530 contains the anti-nausea drug granisetron formulated with the company's proprietary Biochronomer bioerodible drug delivery system. ... RedOrbit FDA Approves Innovative Anti-Nausea Patch - Sep 22, 2008 The patch is worn on the arm, and delivers the anti-nausea medication granisetron through the skin. The first of its kind to hit the US market, ... Invention & Technology News ProStrakan in £13 million Asian deal - May 28, 2008 The patches steadily deliver granisetron – an antiemetic that reduces the activity of a vomit-inducing nerve – into the bloodstream. ... Border Telegraph Hawthorn Pharmaceuticals, Inc. Receives FDA Approval on Granisol(TM) ... - Mar 13, 2008 Granisol(TM) (granisetron HCl) is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer ... Genetic Engineering News - Genetic Engineering News (press release) ProStrakan out-licenses Sancuso in S Korea.(ProStrakan distribution … - Aug 20, 2007 ...a South Korea pharmaceutical company, for Sancuso (transdermal granisetron) patch for the prevention of chemotherapy-induced nausea and vomiting. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com China Pharma Holdings, Inc. Announces Record Fourth Quarter and … - Mar 29, 2007 In 2006, the Company received the Chinese State Food and Drug Administration (SFDA) approval to manufacture and market its granisetron hydrochloride ... $4.95 - PR Newswire - ECNext Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (... - Jan 18, 2007 KYTRIL (granisetron hydrochloride) Tablets, 1mg (base) is indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of ... $4.95 - PR Newswire - ECNext AP Pharma, Inc. Pharmaceutical firm reports 11% increase in revenues,... - Apr 6, 2005 In the fourth quarter of 2004, we evaluated 2.5 mg, 5 mg, and 10 mg doses of the anti-nausea drug granisetron, the active pharmacological agent in APF530, ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Steady stream of new products hits market. - Feb 4, 2008 Roxane also recently rolled out granisetron hydrochloride tablets, 1 mg. The product is available in unit-dose blisters. AB-rated to Kytril, the product has ... $9.94 - Chain Drug Review - Alacra Store Nausea at end of life: think mechanistically.(Geriatrics) - Aug 1, 2007 For chemotherapy-induced nausea and vomiting, the 5-HT3 antagonists ondansetron and granisetron are very effective. Good data support their use in this ... $4.95 - Internal Medicine News - ECNext Press Release: Barr Receives Approval for Generic KYTRIL(R) Tablets, ... - Jan 2, 2008 KYTRIL (granisetron hydrochloride) Tablets, 1 mg (eq to 1 mg base) is indicated for the prevention of: nausea and vomiting associated with initial and ... Pay-Per-View - PR Newswire - HighBeam Research Business Update; Actavis launches three new generic products in Europe - Jun 27, 2006 Granisetron reduces nausea and vomiting, common adverse effects associated with chemotherapy. Each of these products will be marketed by Actavis' European ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |